Quick Answer: Headache is a recognised side effect of GLP-1 receptor agonists, classified as common (1 in 10 to 1 in 100 people) for diabetes formulations and very common (more than 1 in 10) for weight-management doses
Experimental peptides may help to achieve greater gains, but the decision to take them should be discussed with a doctor and/or your fitness coach
Ahlkvist L, Brown K, Ahrn B
This is because they might not get enough from their diet, their body cant absorb it well, and they use more of it
The trial is also designed to provide information on the effect of the normalisation of serum vitamin B12 concentrations by both treatments on patient-perceived quality of life
For many people, particularly men or those with higher body weights, that number falls dangerously close to or below the minimum threshold for adequate nutrition